Research graph
References from Analysis of aggregation profile of glucagon using SEC-HPLC and FFF-MALS methods. Local targets link to admitted publications; unresolved targets remain external evidence.
Factors affecting the physical stability (aggregation) of peptide therapeutics
10.1098/rsfs.2017.0030 · 2017 · External reference
Stabilization challenges and aggregation in protein-based therapeutics in the pharmaceutical industry
10.1039/d3ra06476j · 2023 · External reference
Protein/Peptide Aggregation and Amyloidosis on Biointerfaces
10.3390/ma9090740 · 2016 · External reference
Protein aggregation: pathways, induction factors and analysis
10.1002/jps.21566 · 2009 · External reference
New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions
10.3390/ijms221910643 · 2021 · External reference
A Light Activated Glucagon Trimer with Resistance to Fibrillation
10.1021/acsbiomaterials.1c00031 · 2021 · External reference
Stable Liquid Glucagon: Beyond Emergency Hypoglycemia Rescue
10.1177/1932296818757795 · 2018 · External reference
Unresolved reference
External reference
Size-exclusion chromatography with multi-angle light scattering for elucidating protein aggregation mechanisms
10.1007/978-1-61779-921-1_25 · 2012 · External reference
Theory and practice of size exclusion chromatography for the analysis of protein aggregates
10.1016/j.jpba.2014.04.011 · 2014 · External reference
Use of molecular crowding for the detection of protein self-association by size-exclusion chromatography
10.1016/j.ab.2019.113392 · 2019 · External reference
Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their Aggregates
10.1080/10826076.2012.743724 · 2012 · External reference
The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics
10.1016/j.ejpb.2004.03.034 · 2004 · External reference
New Advances and Applications in Field-Flow Fractionation
10.1146/annurev-anchem-091520-052742 · 2021 · External reference
Characterization of seed nuclei in glucagon aggregation using light scattering methods and field-flow fractionation
10.1186/1754-1611-2-10 · 2008 · External reference
Light Scattering and the Absolute Characterization of Macromolecules
10.1016/0003-2670(93)80373-s · 1993 · External reference
Differential light scattering and the measurement of molecules and nanoparticles: A review
2021 · External reference
Methods for protein characterization by mass spectrometry, thermal shift (ThermoFluor) assay, and multiangle or static light scattering
10.1007/978-1-60327-058-8_19 · 2008 · External reference
Aggregation Analysis of Therapeutic Proteins, Part 2—Analytical Ultracentrifugation and Dynamic Light Scattering
2007 · External reference
Aggregation Analysis of Therapeutic Proteins, Part 3—Principles and Optimization of Field-Flow Fractionation (FFF)
2007 · External reference
Sensitive detection of glucagon aggregation using amyloid fibril-specific antibodies
10.1002/bit.26994 · 2019 · External reference
